The Global Asthma and COPD Drugs Market are anticipated to exhibit a CAGR of 7.90% to extend USD 43,444.72 Million during the review period. The market growth is propelled by the rising prevalence and occurrence of asthma and COPD around the globe. Asthma is a kind of inflammatory disorder that affects the lungs and makes breathing uneasy. Asthma is considered as one of the common chronic condition affecting many people across the world. COPD is an abbreviation of chronic obstructive pulmonary disease in which occurs due to uncontrolled asthma which becomes worse letter; an umbrella term used for a group of respiratory diseases such as emphysema and chronic bronchitis.
The Prominent Players in the Global Asthma and COPD Drugs Market are GlaxoSmithKline plc (UK), AstraZeneca (UK), Boehringer Ingelheim International GmbH (Germany), and Chiesi Farmaceutici SpA (Italy).
Global Asthma and COPD Drugs Market have been categorized into disease, product, route of administration, and distribution channel. The market, based on disease, has been bifurcated into asthma and COPD.
Get Free Sample Report: https://www.wiseguyreports.com/sample-request/5415379-global-asthma-and-copd-drugs-market-research-report-forecast-till-2025
On the basis of the product segment, asthma and COPD drugs market has been divided into long-term asthma control medications and quick-relief medications. The long-term asthma control medications are again divided into combination drugs, anticholinergics, inhaled corticosteroids, long-acting beta-agonists, theophylline, and others. The combination drugs are subcategorized into Seretide/Advair, Symbicort, Relvar/Breo Ellipta, Flutiform, Dulera, and Others. Anticholinergics are further sub-categorized into Spiriva and others. The Inhaled corticosteroids are further divided into Pulmicort, Flovent, Qvar, and others.
The quick-relief medications have been again segmented into short-acting beta-agonists, oral & intravenous corticosteroids, ipratropium bromide (Atrovent), and others. Short-acting beta-agonists have been again bifurcated into Proair and Ventolin.
Global asthma and COPD drugs market, based on the route of administration, has been categorized into oral, inhaled, and others. Based on the distribution channels category, global asthma and COPD drugs market has been segregated into retail pharmacies, hospital pharmacies, and online pharmacies.
Geographically, the Global Asthma and COPD Drugs Market have been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas are likely to lead global asthma and COPD drugs market followed by Europe. The regional market growth is been driven by the rising patient population suffering from asthma and COPD, the increasing health expenditure per person and the growing demand for advanced treatment options. The US contributes the largest market share in the regional market.
The European market for asthma and COPD drugs is evaluated to be the second-largest market of the world during the review period owing to the increasing prevalence of asthma and COPD. The increasing awareness of asthma and COPD in Europe is expected to expand the growth of the regional market.
Asia-Pacific is evaluated to be the rapid-growing market because of the rising awareness of COPD and asthma and high prevalence of asthma and COPD in the region
We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations and many other useful insights.
For Any Query: https://www.wiseguyreports.com/enquiry/5415379-global-asthma-and-copd-drugs-market-research-report-forecast-till-2025
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
5 MARKET FACTOR ANALYSIS
6 GLOBAL ASTHMA AND COPD DRUGS MARKET, BY DISEASE
7 GLOBAL ASTHMA AND COPD DRUGS MARKET, BY PRODUCT
8 GLOBAL ASTHMA AND COPD DRUGS MARKET, BY ROUTE OF ADMINISTRATION
9 GLOBAL ASTHMA AND COPD DRUGS MARKET, BY DISTRIBUTION CHANNEL
10 GLOBAL ASTHMA AND COPD DRUGS MARKET, BY REGION
11 COMPANY PROFILES
Read Other Reports from our Database :
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
Ph: +162 825 80070 (US)
Ph: +44 203 500 2763 (UK)